The living cell harbours complexities that can be harnessed to improve the yield and quality of biological products and thereby increase cost-effectiveness. With the rise of biosimilars, dedicated efforts are necessary to create cost-competitive cell lines.
A range of genetic tools are now available at BTI to shorten timelines for cell line development. Leveraging expertise in both mammalian and microbial expression systems, BTI can optimally select and engineer cell lines to match the target application. Cell lines have been developed in-house for out-licensing, or co-developed with partners.
Visit the following webpages for more information: